The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
News  >  

ASH Names Roy Silverstein 2019 President

Published Online:6:27 PM, Wed January 30, 2019

Roy L. Silverstein, MD

The American Society of Hematology (ASH) has named Roy L. Silverstein, MD, as its 2019 president. He will serve a year-long term through the end of December 2019.

“Hematology is an exciting and rapidly moving discipline driven by research, innovation, and creative thinking in the clinic and in the laboratory,” said Silverstein, chairman of the department of medicine and associate director of the Medical College of Wisconsin Cancer Center. “I am delighted to serve as a leader of the organization that continues to move this field forward.”

During his presidency, Silverstein aims to develop new training programs and innovative pathways in the hematology space for clinicians and researchers. He hopes to accelerate entry into these careers.

Previously, Silverstein has served as the editor-in-chief for ASH’s news magazine, The Hematologist, chaired the Society’s Committee on Government Affairs, co-chaired the 2012 ASH Annual Meeting Scientific Program, and chaired search committees for ASH Clinical News and Blood Advances.

Silverstein is known for his research in platelet and vascular cell biology. His clinical interests include thrombosis, hemostasis, and myeloproliferative neoplasms. He also serves as a senior investigator at the Blood Research Institute at the BloodCenter of Wisconsin.

Silverstein is a graduate of Emory University School of Medicine. He completed his residency and fellowship in hematology and medical oncology at New York Hospital-Cornell Medical Center.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.